Related Experiment Video

Updated: Jun 10, 2026

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
09:17

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Published on: May 2, 2017

Serum cytokines and critical illness-related corticosteroid insufficiency

Yong Soo Kwon1, Gee Young Suh, Kyeongman Jeon

  • 1Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.

Intensive Care Medicine
|July 29, 2010
PubMed

Insights

Elevated cytokines like IL-6, IL-10, and TNF-α are linked to a specific type of critical illness-related corticosteroid insufficiency (CIRCI) with low cortisol response. This finding helps understand CIRCI subgroups better.

Area of Science:

  • Critical care medicine
  • Endocrinology
  • Immunology

Background:

  • Critical illness-related corticosteroid insufficiency (CIRCI) is common in ICUs.
  • Specific cytokine associations with CIRCI subgroups are not well understood.
  • Adrenal function assessment is crucial for managing critically ill patients.

Purpose of the Study:

  • To investigate the association between specific serum cytokine levels and subgroups of patients with CIRCI.
  • To differentiate cytokine profiles in patients with normal adrenal function, low basal cortisol, and low cortisol response.

Main Methods:

  • Retrospective analysis of data from a prospective ICU study on adrenal function.
  • Diagnosis of CIRCI based on basal and stimulated cortisol levels.
  • Categorization of CIRCI patients into low basal cortisol (LBC) and low Δ cortisol (LDC) groups.
  • Comparison of serum cytokine levels (IL-6, IL-10, TNF-α) among normal (NOM), LBC, and LDC groups.

Main Results:

  • Overall CIRCI incidence was 43.9% among 82 analyzed patients.
  • The LDC group (55.6% of CIRCI patients) showed significantly higher IL-6 and IL-10 levels than NOM and LBC groups (p < 0.01).
  • The LDC group also had significantly higher TNF-α compared to the LBC group (p = 0.002).
  • No significant cytokine differences were found between NOM and LBC groups.

Conclusions:

  • Elevated cytokines, particularly IL-6, IL-10, and TNF-α, are associated with adrenal dysfunction in a specific subset of CIRCI patients.
  • The low Δ cortisol subgroup (LDC) exhibits a distinct inflammatory profile compared to those with normal adrenal function or low basal cortisol.
  • These findings contribute to a better understanding of the heterogeneity of CIRCI and its inflammatory underpinnings.
Abstract

More Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...